#IDDF2022
Login
About IDDF
About IDDF
Venue
Named Lectures
e-Poster
e-Poster
Abstract
Call for Abstracts
Awards
Guidelines
About YIA
Case Report
Call for Case Reports
Awards
Guidelines
About Case/Video Champion
Programme
2 Sep
3 Sep
4 Sep
Speaker
Registration
Tickets
Accreditation
Visa
City Attractions
Conference
About IDDF
The Organizer
Venue
Registration Form
1
Main Programme
2
Accreditations
3
Order Summary
4
Confirmation
Sort by date
Sort by category
Programme
Gastroenterology
Hepatology
Endoscopy
Basic Science
Lecture Theatre 1B
2022-09-03
15:50-17:05
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
15:50
Genetic and epigenetic alterations in gastric cancer
16:15
Mettl3 as a therapeutic target in colorectal cancer
Huarong CHEN
16:40
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
Lecture Theatre 1B
2022-09-03
17:05-18:20
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
17:05
Enterically derived HDL restrains liver injury through the portal vein
Gwendalyn RANDOLPH
17:30
Intestine gene regulates NAFLD through gut-liver axis
Jennifer Zhang
17:55
Fecal mycobiome in NAFLD
Bernd SCHNABL
Lecture Theatre 1B
2022-09-04
09:00-10:30
State Key Lab Meeting (3) - Microbiome and host response
09:00
Microbiome in GI cancer
09:30
Genetic stability and individual specificity of the human gut microbiome
10:00
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
Rhonda SOUZA
Lecture Theatre 1B
2022-09-04
11:00-12:30
State Key Lab Meeting (4) - Microbiome and cancer therapy
11:00
Microbiome and anti-cancer therapy
11:30
Enterococcus and cancer immunotherapy
12:00
Targeting microbiome for cancer prevention/treatment
Lecture Theatre 1A
2022-09-04
14:30-16:00
COVID-19 and the GUT: lessons learnt
14:30
Gut microbiome and vaccine response
15:00
COVID-19 vaccine and immunosuppressants: chicken or egg?
Gilaad KAPLAN
15:30
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
Martin WONG
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
Lecture Theatre 1B
2022-09-03
15:50
15:50
Genetic and epigenetic alterations in gastric cancer
16:15
Mettl3 as a therapeutic target in colorectal cancer
Huarong CHEN
16:40
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
Lecture Theatre 1B
2022-09-03
17:05
17:05
Enterically derived HDL restrains liver injury through the portal vein
Gwendalyn RANDOLPH
17:30
Intestine gene regulates NAFLD through gut-liver axis
Jennifer Zhang
17:55
Fecal mycobiome in NAFLD
Bernd SCHNABL
State Key Lab Meeting (3) - Microbiome and host response
Lecture Theatre 1B
2022-09-04
09:00
09:00
Microbiome in GI cancer
09:30
Genetic stability and individual specificity of the human gut microbiome
10:00
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
Rhonda SOUZA
State Key Lab Meeting (4) - Microbiome and cancer therapy
Lecture Theatre 1B
2022-09-04
11:00
11:00
Microbiome and anti-cancer therapy
11:30
Enterococcus and cancer immunotherapy
12:00
Targeting microbiome for cancer prevention/treatment
COVID-19 and the GUT: lessons learnt
Lecture Theatre 1A
2022-09-04
14:30
14:30
Gut microbiome and vaccine response
15:00
COVID-19 vaccine and immunosuppressants: chicken or egg?
Gilaad KAPLAN
15:30
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
Martin WONG
Close